Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/28330
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2022-08-24T05:55:07Z-
dc.date.available2022-08-24T05:55:07Z-
dc.date.issued2010-12-
dc.identifier.citationDemirkaya, M. vd. (2010). "Lenfoma ve solid tümörlü çocuklarda febril nötropeni: Tek merkez deneyimi". Türk Pediatri Arşivi, 45(4), 353-358.tr_TR
dc.identifier.issn1306-0015-
dc.identifier.urihttps://doi.org/10.4274/tpa.45.353-
dc.identifier.urihttps://dergipark.org.tr/tr/download/article-file/141012-
dc.identifier.urihttp://hdl.handle.net/11452/28330-
dc.description.abstractAim: The objective of this study is to evaluate the febrile neutropenia attacks in the children who have been treated for cancer in our center. Material and Method: Between January 2000 and December 2005, 57 patients with lymphoma and solid organ tumors who, had a total of 206 attacks of febril neutropenia were evaluated retrospectively. Results: The mean absolute neutrophil count (ANC), absolute lymphocyte count (ALC), absolute monocyte count (AMC) levels at the time of febril neutropenia attacks were 296 +/- 342/mm(3), 518 +/- 896/mm(3), 144 +/- 262/mm(3), respectively. The mean C-reactive protein (CRP) level was 7.63 +/- 7.06 mg/dL, Hb level was 8.67 +/- 1.74 g/dL and fever was 38.5 +/- 0.2 degrees C. There were no infection focus in the 57.3% of the attacks (n=118) and the most common infection focuses were pharyngitis and mucositis and they were seen in the 14% and 12.1% of the attacks, respectively. Combination of third generation cephalosporins and aminoglycosides were given in 87.8% (n=181) of the attacks. Bacteremia was found in 14.6% (n=30). The rate of isolated gram negative bacteria (60%) was higher than the others. The most common agents isolated were E.coli, Enterobacter cloaca and S.epidermidis in 16.7%, 13.3% and 13.3%, respectively. The success rate of therapy was found as 67.5%. There were no correlations between the infection focus and AMC, ANC, CRP levels, and mucositis and bacteremia. The presence of mucositis prolonged the duration of hospitalization. There were no significant differences between therapy regimens according to success of therapy, bacteremia and duration of hospitalization. The duration of neutropenia was longer in neuroblastoma and brain tumors. The mortality rate was found as 1.45%. Conclusions: The rate of gram negative bacteremia was higher in our study. None of our patients had central venous catheters, so we thought that this could be the reason to the lower rate of isolated gram positive bacteria. The response rate to the treatment was good and mortality rate was low with the empirical treatment by cephalosporin and aminoglycoside combination.en_US
dc.language.isotrtr_TR
dc.publisherTürk Pediatri Derneğitr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectChilden_US
dc.subjectCanceren_US
dc.subjectFebrile neutropeniaen_US
dc.subjectPediatric cancer-patientsen_US
dc.subjectPlus amikacinen_US
dc.subjectEmpirical treatmenten_US
dc.subjectOncology patientsen_US
dc.subjectLow-risken_US
dc.subjectFeveren_US
dc.subjectMonotherapyen_US
dc.subjectCefepimeen_US
dc.subjectPiperacillin/tazobactamen_US
dc.subjectManagementen_US
dc.subjectPediatricsen_US
dc.subjectÇocuken_US
dc.subjectKanseren_US
dc.subjectFebril nötropenien_US
dc.titleFebrile neutropenia in children with lymphoma and solid tumors: One center experienceen_US
dc.title.alternativeLenfoma ve solid tümörlü çocuklarda febril nötropeni: Tek merkez deneyimien_US
dc.typeArticleen_US
dc.identifier.wos000285538800010tr_TR
dc.identifier.scopus2-s2.0-78650702070tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı.tr_TR
dc.identifier.startpage353tr_TR
dc.identifier.endpage358tr_TR
dc.identifier.volume45tr_TR
dc.identifier.issue4tr_TR
dc.relation.journalTürk Pediatri Arşivitr_TR
dc.contributor.buuauthorDemirkaya, Metin-
dc.contributor.buuauthorÖzgür, Taner-
dc.contributor.buuauthorÇelebi, Solmaz-
dc.contributor.buuauthorSevinir, Betül Berrin-
dc.contributor.buuauthorHacımustafaoğlu, Mustafa Kemal-
dc.contributor.researcheridAAG-8381-2021tr_TR
dc.contributor.researcheridAAH-1570-2021tr_TR
dc.indexed.trdizinTrDizinen_US
dc.subject.wosPediatricsen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.contributor.scopusid24331130000tr_TR
dc.contributor.scopusid36087775800tr_TR
dc.contributor.scopusid7006095295tr_TR
dc.contributor.scopusid6603199915tr_TR
dc.contributor.scopusid6602154166tr_TR
dc.subject.scopusCancer; Coagulase Negative Staphylococci; Piperacillin Plus Tazobactamen_US
dc.subject.emtreeAminoglycosideen_US
dc.subject.emtreeC reactive proteinen_US
dc.subject.emtreeCephalosporinen_US
dc.subject.emtreeHemoglobinen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBacteremiaen_US
dc.subject.emtreeBrain tumoren_US
dc.subject.emtreeCancer centeren_US
dc.subject.emtreeEnterobacter cloacaeen_US
dc.subject.emtreeEscherichia colien_US
dc.subject.emtreeFebrile neutropeniaen_US
dc.subject.emtreeFeveren_US
dc.subject.emtreeHospitalizationen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeInfectionen_US
dc.subject.emtreeLymphocyte counten_US
dc.subject.emtreeLymphomaen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMonocyteen_US
dc.subject.emtreeMortalityen_US
dc.subject.emtreeMucosa inflammationen_US
dc.subject.emtreeNeuroblastomaen_US
dc.subject.emtreeNeutrophil counten_US
dc.subject.emtreePharyngitisen_US
dc.subject.emtreeSolid tumoren_US
dc.subject.emtreeStaphylococcus epidermidisen_US
Appears in Collections:Scopus
TrDizin
Web of Science

Files in This Item:
File Description SizeFormat 
Demirkaya_vd_2010.pdf69.72 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons